ReviewFrontiers in genome editing2022
Implications and Lessons From the Introduction of Genome-Edited Food Products in Japan.
Review in Frontiers in genome editing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 26 citations in OpenAlex.
- Review
- From designer babies to edited food: comparing public attitudes toward CRISPR technology and gene editing in Japan and the United States.BMC medical ethics · 2026Article
- Achieving bottom-up ethical, legal, and societal implications and responsible research and innovation in the synthetic biology research community from the Japanese context.Frontiers in genetics · 2026Article
- AI-enhanced framework for optimizing CRISPR-Cas gene editing in crop biotechnology addressing regulatory challenges and opportunities in global agricultural practices.Frontiers in plant science · 2026Article
- Genome-Edited Fish in the Field.Current issues in molecular biology · 2025Review
- Epigenomics and Non-Coding RNAs in Soybean Adaptation to Abiotic Stresses.International journal of molecular sciences · 2025Review
- Current and future uses of genetic improvement technologies in livestock breeding programs.Animal frontiers : the review magazine of animal agriculture · 2025Article
- The decision to purchase genome edited food products by Iranian consumers: theory of planned behavior as a social intervention tool.Frontiers in genome editing · 2025Article
- Growing knowledge impact of gene-editing technology on public acceptance: a longitudinal analysis in Japan.GM crops & food · 2024Article
- Synthetic biology in plants.Plant biotechnology (Tokyo, Japan) · 2024Article
- Global regulatory trends of genome editing technology in agriculture and food.Breeding science · 2024Article
- Global regulatory policies for animal biotechnology: overview, opportunities and challenges.Frontiers in genome editing · 2024Review
- A comparative analysis of attitudes toward genome-edited food among Japanese public and scientific community.PloS one · 2024Article
- Providing appropriate information to consumers boosts the acceptability of genome-edited foods in Japan.GM crops & food · 2023Article
- Regulation of plants developed through new breeding techniques must ensure societal benefits.Nature plants · 2023Article
- Divergence and convergence in international regulatory policies regarding genome-edited food: How to find a middle ground.Frontiers in plant science · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Japan clarified its regulatory approaches for products derived from genome editing technologies in 2019. Consequently, Japan has become a pioneer in the social implementation of such technologies, as to date, the notification process for three products, GABA-enriched tomato, fleshier red sea bream, and high-growth tiger puffer, has been completed. However, this has led to questions about how this was achieved, given the poor consumer acceptance and low public support for genetically modified (GM) foods in the past. This paper describes Japan's regulatory approaches and their implementation guidelines for products created using genome editing technologies. It explains the governance of genome editing technologies and how the derived products have been introduced into society. The three factors that made this possible include: 1) improved R&D environments as a result of government-led innovation policy and regulations which have sought a balance between science and social demand 2) changes in the players (i.e. university startups), that engage in R&D and the strategies used for social introduction, and 3) social value changes-the recent rise in momentum for sustainable development goals (SDGs) and environmental, social, and governance (ESG) investing. The lessons and challenges in terms of R&D policy development and regulation from these analyses are presented. As the market size and social impact of genome-edited food products is limited, it is too early to fully assess this topic for Japan and thus, the analysis in this study is preliminary and must be revisited in the coming years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.